ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+3.12%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$858M
AUM Growth
+$858M
(+21%)
Cap. Flow
+$135M
Cap. Flow
% of AUM
15.76%
Top 10 Holdings %
Top 10 Hldgs %
62.43%
Holding
37
New
13
Increased
6
Reduced
3
Closed
15
Top Buys
| 1 |
Agilent Technologies
A
|
$80.1M |
| 2 |
Globus Medical
GMED
|
$69.8M |
| 3 |
AbbVie
ABBV
|
$66.5M |
| 4 |
UnitedHealth
UNH
|
$61.1M |
| 5 |
Boston Scientific
BSX
|
$44.2M |
Top Sells
| 1 |
Elanco Animal Health
ELAN
|
$62.6M |
| 2 |
Illumina
ILMN
|
$57.4M |
| 3 |
Tenet Healthcare
THC
|
$51.3M |
| 4 |
Acadia Healthcare
ACHC
|
$50.9M |
| 5 |
Oscar Health
OSCR
|
$34.2M |
Sector Composition
| 1 | Healthcare | 97.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Agilent Technologies
A
$35.7B
| $80.1M | 8.82% | +596,326 | New | +$80.1M |
|
|
2
Globus Medical
GMED
$8.27B
| $69.8M | 7.68% | +844,013 | New | +$69.8M |
|
|
3
AbbVie
ABBV
$372B
| $66.5M | 7.32% | +374,012 | New | +$66.5M |
|
|
4
UnitedHealth
UNH
$281B
| $61.1M | 6.72% | +120,700 | New | +$61.1M |
|
5
Teva Pharmaceuticals
TEVA
$21.1B
| $48.5M | 5.34% | 2,200,036 +256,246 | +13% | +$5.65M |
|
|
6
Boston Scientific
BSX
$156B
| $44.2M | 4.87% | +495,009 | New | +$44.2M |
|
7
Neurocrine Biosciences
NBIX
$13.8B
| $43.4M | 4.78% | +318,195 | New | +$43.4M |
|
8
Envista
NVST
$3.52B
| $42.4M | 4.67% | 2,200,000 +10,631 | +0.5% | +$205K |
|
9
Insulet
PODD
$23.9B
| $40.2M | 4.43% | 154,014 +44,014 | +40% | +$11.5M |
|
10
Merit Medical Systems
MMSI
$5.36B
| $39.4M | 4.33% | 407,022 +154,022 | +61% | +$14.9M |
|
11
Intuitive Surgical
ISRG
$170B
| $39.1M | 4.31% | 75,000 +2,999 | +4% | +$1.57M |
|
12
DaVita
DVA
$9.85B
| $38.9M | 4.29% | +260,424 | New | +$38.9M |
|
13
Exact Sciences
EXAS
$8.98B
| $33.7M | 3.71% | 600,000 +200,129 | +50% | +$11.2M |
|
14
HealthEquity
HQY
$7.72B
| $32.2M | 3.54% | +335,614 | New | +$32.2M |
|
15
Medpace
MEDP
$13.4B
| $29.9M | 3.29% | 90,000 -102,842 | -53% | -$34.2M |
|
16
Twist Bioscience
TWST
$1.63B
| $22.9M | 2.52% | 492,471 -17,529 | -3% | -$815K |
|
17
SPDR S&P Biotech ETF
XBI
$5.07B
| $22.5M | 2.48% | +250,000 | New | +$22.5M |
|
18
Glaukos
GKOS
$5.5B
| $22.5M | 2.48% | 150,000 -67,674 | -31% | -$10.1M |
|
19
Cardinal Health
CAH
$35.5B
| $22M | 2.42% | +186,002 | New | +$22M |
|
20
argenx
ARGX
$43.6B
| $21.5M | 2.37% | +35,000 | New | +$21.5M |
|
|
WAY
21
Waystar Holding Corp
WAY
$6.6B
| $20.3M | 2.23% | +551,893 | New | +$20.3M |
|
22
Doximity
DOCS
$12.7B
| $16.7M | 1.84% | +312,575 | New | +$16.7M |
|
23
Acadia Pharmaceuticals
ACAD
$4.38B
| – | – | -750,000 | Closed | -$11.5M |
|
|
24
Acadia Healthcare
ACHC
$2.12B
| – | – | -802,151 | Closed | -$50.9M |
|
25
Axsome Therapeutics
AXSM
$6.05B
| – | – | -252,266 | Closed | -$22.7M |
|